Skip to main content

Our Team

Meet the visionary team behind Psycheceutical

Led by world-class neurosurgeons, our multidisciplinary team incorporates clinical and basic neurosciences to revolutionize our understanding and ability to treat a variety of neurological and neuropsychiatric conditions.

Leadership Team

Click to read each team member’s bio

Neilank K. Jha, MD

Chief Executive Officer

Chad Harman

President

Kevin Harrington

Strategic Advisor

Michael Hlavsa

Chief Financial Officer

Medical Advisory Board

Julian E. Bailes, MD

Chief Medical Officer

Dr. Thomas Cabell

Medical Advisor

Dr. Tony Strickland

Medical Advisor

Science Team

Ronald Aung-Din, MD

Clinical Advisor

Dr. James Cappola

Clinical Advisor

Advisory Team

Dr. John Kutzko

Formulations Advisor

Dr. Zachary Clayton

Research Advisor

Dan Yerace

Strategic Advisor

Psycheceutical Bioscience, Inc. is developing cutting-edge technologies to advance the safe and effective delivery of psychedelic pharmaceutical medicines.

© 2026 Psycheceutical, Inc. All Rights Reserved. Website by Domino Brand Consulting.

Legal Disclaimer

Privacy Policy

Neilank K. Jha, MD
Chief Executive Officer & Executive Chairman

Neilank K. Jha, MD, MSc, MBA, completed his residency in neurosurgery and fellowship in Spinal Surgery and is a recognized leader in the field of mild Traumatic Brain Injury (mTBI). He completed his MBA with a focus on Forensic Accounting & Data Analytics from Ivey Business School and his MSc from the London School of Economics in Behavioural Economics and Cognitive Psychology.

Chad Harman
President

Chad Harman is a 25-year cannabis and health insurance executive possessing unique leadership experience across operations, manufacturing, finance, product development, etc. Chad’s strength lies in focused corporate strategies to maximize efficiency and profitability.

Kevin Harrington
Strategic Advisor

Kevin Harrington is an entrepreneur, investor, business executive and best-selling author. He was one of the original members and investors (“sharks”) on the hit TV series Shark Tank. Harrington has been involved in over 500 product launches that have resulted in over $5 billion in sales.

Michael Hlavsa
Chief Financial Officer

Michael Hlavsa has 44 years of executive and financial experience, receiving designations of CPA, certified internal auditor, and chartered global management accountant. He’s been an officer and director of numerous publicly traded companies on the NYSE, NASDAQ and OTCBB.

Julian E. Bailes, MD
Chief Medical Officer

Julian E. Bailes, MD is a recognized leader in the field of neurosurgery and the impact of brain injury on brain function. He’s been instrumental in the understanding of Chronic Traumatic Encephalopathy (CTE). He was portrayed by the actor Alec Baldwin in the movie Concussion.

Dr. Thomas Cabell
Medical Advisor

Dr. Thomas Cabell is a cardiologist and is affiliated with the Centennial Heart group. Dr. Cabell is passionate about bringing awareness to and understanding the importance of emotional/mental health as it relates to physical health and disease.

Dr. Tony Strickland
Medical Advisor

Dr. Tony Strickland is a board-certified neuropsychologist and a retired associate clinical professor of neurology at the UCLA David Geffen School of Medicine. Dr. Strickland established the Center for Postconcussion Syndrome and PTSD Treatment.

Ronald Aung-Din, MD
Clinical Advisor

Dr. Ronald Aung-Din practices General Neurology and Neuro-Psychiatry in Sarasota, Florida. He is board-certified by the American Board of Psychiatry and Neurology and a member of the American Academy of Neurology. He has participated as Principal Investigator in over 50 industry-sponsored clinical trials.

Dr. James Cappola
Clinical Advisor

Dr. James J. Cappola has over 25 years experience for Clinical Research and Pharmacovigilance of drugs, biologics and devices development. He also has Medical Affairs product launch experience in Pharma and CRO environments, as well as medical monitoring for Phase I, II, III, and post marketing clinical studies.

Dr. John Kutzko
Formulations Advisor

Dr. Kutzko has entrepreneurial experience in addition to consultancy and senior level operations management experience in the delivery of USP 795 and USP 797 compounding, home infusion services, specialty pharmacy services and medical devices. He also had full P&L oversight and responsibility for pharmacy operations throughout the southeastern U.S.

Dr. Zachary Clayton
Research Advisor

Dr. Zachary Clayton is an experienced researcher with expertise in designing fully translational preclinical studies that allow for maximum efficiency while creating reliable, applicable results intended to directly benefit human health. Dr. Clayton is a sought-after conference presenter and guest lecturer, and his research expertise is evidenced by authoring or co-authoring more than 35 peer-reviewed research publications to date.

Dan Yerace
Strategic Advisor

Mr. Yerace is a co-founder of Coeptis Pharmaceuticals and serves as the Vice President of Operations. Dan is the key strategist responsible for supply chain management, business development, portfolio management, and corporate strategy.